...
首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.
【24h】

Induction of glomerular heparanase expression in rats with adriamycin nephropathy is regulated by reactive oxygen species and the renin-angiotensin system.

机译:阿霉素肾病大鼠肾小球乙酰肝素酶表达的诱导受活性氧和肾素-血管紧张素系统的调节。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Heparan sulfate (HS) in the glomerular basement membrane (GBM) is important for regulation of the charge-dependent permeability. Heparanase has been implicated in HS degradation in several proteinuric diseases. This study analyzed the role of heparanase in HS degradation in Adriamycin nephropathy (AN), a model of chronic proteinuria-induced renal damage. Expression of heparanase, HS, and the core protein of agrin (to which HS is attached) was determined on kidney sections from rats with AN in different experiments. First, expression was examined in a model of unilateral AN in a time-course study at 6-wk intervals until week 30. Second, rats were treated with the hydroxyl radical scavenger dimethylthiourea (DMTU) during bilateral AN induction. Finally, 6 wk after AN induction, rats were treated with angiotensin II receptor type 1 antagonist (AT1A) or vehicle for 2 wk. Heparanase expression was increased in glomeruli of rats with AN, which correlated with HS reduction at all time points and in all experiments. Treatment with DMTU prevented the increased heparanase expression, the loss of GBM HS, and reduced albuminuria. Finally, treatment of established proteinuria with AT1A significantly reduced heparanase expression and restored glomerular HS. In conclusion, an association between heparanase expression and reduction of glomerular HS in AN was observed. The effects of DMTU suggest a role for reactive oxygen species in upregulation of heparanase. Antiproteinuric treatment by AT1A decreased heparanase expression and restored HS expression. These results suggest involvement of radicals and angiotensin II in the modulation of GBM permeability through HS and heparanase expression.
机译:肾小球基底膜(GBM)中的硫酸乙酰肝素(HS)对于调节电荷依赖性渗透性很重要。乙酰肝素酶与几种蛋白尿疾病的HS降解有关。这项研究分析了乙酰肝素酶在阿霉素肾病(AN)(一种慢性蛋白尿引起的肾损伤的模型)中HS降解中的作用。在不同的实验中,在患有AN的大鼠的肾脏切片上测定了乙酰肝素酶,HS和凝集素核心蛋白(与HS连接的蛋白)的表达。首先,在一个时程研究中,以6周的间隔直到30周,在单侧AN模型中检查表达。第二,在双侧AN诱导过程中,用羟基自由基清除剂二甲基硫脲(DMTU)处理大鼠。最后,在AN诱导后6周,大鼠接受1型血管紧张素II受体拮抗剂(AT1A)或赋形剂治疗2周。在所有时间点和所有实验中,AN大鼠的肾小球中乙酰肝素酶表达均增加,这与HS降低有关。 DMTU处理可防止乙酰肝素酶表达增加,GBM HS丢失和蛋白尿减少。最后,用AT1A治疗既定的蛋白尿可显着降低乙酰肝素酶表达并恢复肾小球HS。总之,观察到乙酰肝素酶表达与AN中肾小球HS降低之间的关联。 DMTU的作用表明活性氧在乙酰肝素酶上调中起作用。 AT1A的抗蛋白尿治疗可降低乙酰肝素酶的表达并恢复HS的表达。这些结果表明自由基和血管紧张素II通过HS和乙酰肝素酶表达参与GBM渗透性的调节。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号